Friedman v. Federal Aviation Administration , 841 F.3d 537 ( 2016 )


Menu:
  •  United States Court of Appeals
    FOR THE DISTRICT OF COLUMBIA CIRCUIT
    Argued September 23, 2016         Decided November 15, 2016
    No. 16-1007
    ERIC FRIEDMAN,
    PETITIONER
    v.
    FEDERAL AVIATION ADMINISTRATION,
    RESPONDENT
    On Petition for Review of an Order
    of the Federal Aviation Administration
    Z.W. Julius Chen argued the cause for Petitioner. With
    him on the briefs were Gregory S. Walden and William
    Mongan. Pratik A. Shah entered an appearance.
    Amanda Kate Bruchs, Attorney, Federal Aviation
    Administration, argued the cause and filed the brief for
    Respondent. Michael S. Raab and Abby C. Wright, Attorneys,
    U.S. Department of Justice, entered appearances.
    Neal Kumar Katyal and Jaclyn L. DiLauro were on the
    brief for amicus curiae The American Diabetes Association in
    support of Petitioner.
    Before: ROGERS, BROWN and PILLARD, Circuit Judges.
    2
    Opinion for the Court filed by BROWN, Circuit Judge.
    BROWN, Circuit Judge:
    “I’ve never known an industry that can get into people’s
    blood the way aviation does.”
    - Robert Six, founder of Continental Airlines
    Petitioner Eric Friedman (“Friedman”), a commercial
    airline pilot, claims Respondent Federal Aviation
    Administration (“the FAA” or “the Agency”) has behaved in
    an arbitrary and capricious manner in assessing his request for
    a commercial airline pilot’s license. Friedman has been
    diagnosed with Insulin Treated Diabetes Mellitus (“ITDM”),
    and although he holds a third class medical certificate
    authorizing him to pilot non-commercial flights in the United
    States, he seeks the first class certificate necessary to serve as
    a commercial airline pilot.          He argues the FAA has
    impermissibly conditioned issuance of a first class license on
    ninety days of continuous blood glucose monitoring, a costly
    and invasive procedure not medically necessary for his care.
    Since we believe the Agency’s unwavering position
    constitutes final action, we remand to the FAA to provide
    reasons for its denial.
    I.
    Congress has granted the FAA broad authority to regulate
    those “practices, methods, and procedure[s] the Administrator
    finds necessary for safety in air commerce and national
    security.” 49 U.S.C. § 44701(a)(5). Accordingly, the FAA
    issues airman certificates to pilots who are “qualified for, and
    physically able to perform the duties related to, the position.”
    
    Id. § 44703(a).
    The Agency has also established rules
    requiring pilots to hold both a medical certificate and a pilot
    3
    certificate. See, e.g., 14 C.F.R. § 61.3(a) & (c). The FAA
    lists a number of conditions generally disqualifying for any
    class of medical certification, among them a “medical history
    or clinical diagnosis of diabetes mellitus that requires insulin
    or any other hypoglycemic drug for control,” otherwise
    known as ITDM. 14 C.F.R. §§ 67.113(a), 67.213(a),
    67.313(a). While a diagnosis of ITDM generally excludes a
    pilot from any medical certificate issued by the FAA pursuant
    to 49 U.S.C. § 44703(a), the FAA has the discretionary
    authority to grant exceptions to the medical regulations
    contained in 14 C.F.R. § 67. See 49 U.S.C. § 44701(f). An
    Authorization for Special Issuance of a Medical Certificate
    may be provided to an applicant with a disqualifying
    condition “if the person shows to the satisfaction of the
    Federal Air Surgeon that the duties authorized by the class of
    medical certificate applied for can be performed without
    endangering public safety during the period in which the
    Authorization would be in force.” 14 C.F.R. § 67.401(a).
    Regulations require the Federal Air Surgeon (“FAS”) to
    make his determination using standards published for each
    condition as set forth in the FAA’s Guide to Aviation Medical
    Examiners (“AME Guide”). See 
    id. § 67.407(a).
    The process
    includes a medical examination performed by a member of
    the community of Aviation Medical Examiners (“AME”s),
    see 
    id. § 67.401(a),
    and it may require pilots to provide
    additional medical information to the FAA where necessary,
    see 
    id. § 67.413(a).
    Specifically, the FAS must “consider[]
    the need to protect the safety of persons and property in other
    aircraft and on the ground.” 
    Id. § 67.401(e).
    For much of its history the FAA enforced a blanket ban
    on the issuance of medical certificates to individuals with
    ITDM, but in 1996 it reversed course and established criteria
    for pilots with ITDM to receive a third class medical
    4
    certificate (but not a first class certificate). Since the policy
    change was adopted, there has been no medically related
    accident, incident, or inflight incapacitation, from any cause,
    of any such insulin treated special issuance pilot. In light of
    the strong record of third class pilots with ITDM, and in
    reliance on the expert analysis provided by an Expert Panel on
    Pilots with Insulin Treated Diabetes (“Expert Panel”)—
    convened by the American Diabetes Association (“ADA”) at
    the FAA’s request—the FAA amended its AME Guide to
    broaden the third class ITDM protocol to all classes of
    medical certificates on April 21, 2015.
    On April 27, 2015, Friedman submitted a completed
    application for a first class license to the FAA. A few days
    later, on April 30, 2015, the FAA requested supplemental
    information, including “any and all information that you may
    have that is relevant to your condition, which may include . . .
    (if applicable) continuous glucose monitor readings.” JA 73.
    The next month, Friedman inquired as to the FAA’s method
    for evaluating glucose testing results and stated “I do not use
    a continuous glucose monitor.” JA 31–32. Continuous
    Glucose Monitoring (“CGM”), according to the ADA, is an
    invasive procedure that “uses a sensor inserted under the skin
    to check glucose levels in tissue fluid. A transmitter sends
    information about glucose levels via radio waves from the
    sensor to a wireless monitor.” ADA Amicus Br. 14. This
    technique provides a “historical record of glucose levels over
    time” and can “provid[e] helpful information about historic
    trends in one’s blood sugar levels and how those levels have
    been affected by diet and exercise.” 
    Id. However, CGM
    data
    is not as accurate as other blood glucose measures like
    fingersticks. 
    Id. 15–16. Moreover,
    CGM is costly and is not
    covered by insurance unless medically necessary.
    5
    On June 17, 2015, just two days after Friedman wrote to
    the FAA to note the Agency had requested information
    beyond its own published evaluation protocol, the FAA
    revised its AME Guide. The newly-minted version provided
    “[f]irst and second class applicants will be evaluated on a
    case-by-case basis by the Federal Air Surgeon’s Office” and
    omitted any protocol for evaluation. JA 469. Later, on
    October 6, 2015, the FAA again requested Friedman provide
    “any and all information that you may have that is relevant to
    your condition, which may include . . . [a] report for
    continuous glucose monitoring (CGM) conducted for a
    minimum of 90 days.” JA 71. The letter informed Friedman
    his application would be denied if he did not indicate he
    planned to comply with the request within sixty days. JA 72.
    In response, Friedman again advised the FAA he did not
    possess any CGM data. This time, however, Friedman also
    presented letters from his physicians explaining CGM was not
    medically necessary in his case. The Expert Panel even
    submitted a letter in support of Friedman’s application to
    explain, “CGM systems have value, [but] they are neither
    necessary nor appropriate for making decisions on medical
    certification of pilots with diabetes” and are less accurate than
    the blood glucose data Friedman had already submitted. JA
    65–66. On November 13, 2015, the FAA wrote to Friedman
    yet again to request CGM data and again cautioned that
    failure to respond within thirty days with an agreement to
    supply CGM data would result in denial of his application.
    Thereafter, on December 1, 2015, the FAA wrote
    Friedman to explain it was “unable to proceed with further
    determination of [his] potential eligibility for special issuance
    of a first-class airman medical certificate until [the Agency]
    receive[d] the [CGM] information previously requested . . . .”
    JA 53. On December 18, 2015, the FAS sent an additional
    letter informing Friedman his request for a first class
    6
    certification “remains under consideration” and granting him
    a third class certificate—the certificate level he already held.
    JA 47–48. 1 Specifically, the letter noted the FAS had
    reviewed the information submitted in Friedman’s April 27,
    2015 application and granted the third class license in
    response. 
    Ibid. It further advised
    Friedman “should not
    undergo a new FAA medical examination until advised to do
    so by the Aerospace Medicine Certification Division
    (AMCD).” JA 48.
    II.
    The threshold question in this case is whether the FAA
    has, either actually or impliedly, issued a final order eligible
    for judicial review. The Administrative Procedure Act
    (“APA”) authorizes judicial review of “final agency action for
    which there is no other adequate remedy in a court,” and
    “[a]gency action made reviewable by statute.” 5 U.S.C.
    § 704. And, while Section 46110 of the Federal Aviation Act
    authorizes judicial review of an “order” and omits any explicit
    finality requirement, this Circuit has “incorporated generally
    applicable finality principles into the analysis of what counts
    as an ‘order’ under section 46110.” Flytenow, Inc. v. FAA,
    
    808 F.3d 882
    , 888–89 (D.C. Cir. 2015).
    Here, the FAA contends it did not issue a final order
    regarding Friedman’s first class medical certificate
    1
    On November 12, 2015, Friedman had applied to the FAA for a
    renewal of his third class medical certificate due to expire on
    December 31, 2015. While Friedman alleges the FAA altered his
    first class application in granting his request for a third class
    certificate, he has presented no evidence suggesting this was done
    in bad faith. Without evidence to the contrary, “[w]e must presume
    an agency acts in good faith.” Comcast Corp. v. FCC, 
    526 F.3d 763
    , 769 n.2 (D.C. Cir. 2008).
    7
    application; it purportedly ruled solely on his independent
    request for a third class medical certificate and specifically
    indicated the first class certificate remained under review.
    See JA 47–48, 53. Accordingly, the Court initially considers
    whether the Agency’s admitted actions nonetheless meet the
    two-part test of finality:
    First, the action must mark the consummation of the
    agency’s decisionmaking process—it must not be of
    a merely tentative or interlocutory nature. And
    second, the action must be one by which rights or
    obligations have been determined, or from which
    legal consequences will flow.
    Bennett v. Spear, 
    520 U.S. 154
    , 177–78 (1997). Case law
    interpreting this standard is “hardly crisp,” and it “lacks many
    self-implementing, bright-line rules, given the pragmatic and
    flexible nature of the inquiry as a whole.” Rhea Lana, Inc. v.
    Dep’t of Labor, 
    824 F.3d 1023
    , 1027 (D.C. Cir. 2016). As a
    general principle, therefore, “the term ‘order’ in [Section
    46110] should be read expansively.” City of Dania Beach v.
    FAA, 
    485 F.3d 1181
    , 1187 (D.C. Cir. 2007).
    The specific facts presented here establish a constructive
    denial of Friedman’s application for a first class certificate.
    In its October 6, 2015 letter, the FAA first expressly
    required CGM data from Friedman: the Agency warned it
    would “deny [his] request for upgrade” to a first class
    certificate if he did not “reply within 60 days . . . [to] advise
    [the FAA] of [his] plans” to provide the requested data. JA
    72; see 14 C.F.R. § 67.413(a) & (b) (noting an applicant
    “must” provide requested supplemental information and
    authorizing the FAA to “deny the application for a medical
    certificate” for those who fail to comply). Friedman refused.
    Thereafter, on November 13, 2015—about one month after
    8
    the FAA’s countdown clock started—the FAA repeated its
    demand, and it requested a “reply within 30 days.” JA 55.
    The Agency was clearly counting down towards a denial on
    December 13, 2015, and yet Friedman continued to explain
    that he did not possess or intend to procure the requested
    CGM data.          Then, in its December 1, 2015 letter
    acknowledging communication from Friedman’s attorney, the
    FAA ignored the ticking clock. Instead, it merely noted, “We
    are unable to proceed with further determination of your
    potential eligibility for special issuance of a first-class airman
    medical certificate until we receive the information previously
    requested in our letter of November 13, 2015. We look
    forward to reviewing that information when you are able to
    provide it.” JA 53. Thereafter, in its only communication
    authored after the thirty-day deadline had passed, the FAA
    acknowledged Friedman’s “request for upgrade[d] first-class
    special issuance medical certification remains under
    consideration,” but it failed to offer an extension of the
    previously-set deadline or otherwise establish any timetable
    for denial of Friedman’s application for failure to comply. JA
    47 (December 18, 2015 letter).
    Here, the FAA has issued no formal decision on
    Friedman’s application for a first class certificate. Despite his
    consistent refusal to provide the requested CGM data, the
    Agency has placed Friedman in a holding pattern—preventing
    him from obtaining any explicitly final determination on his
    application and thwarting the Court’s interest in reviewing
    those agency actions that, in practical effect if not formal
    acknowledgement, constitute “the consummation of the
    agency’s decisionmaking process” and determine “rights or
    obligations.” 
    Bennett, 520 U.S. at 177
    –78; see also 5 U.S.C.
    § 551(13) (defining agency “action” to include a “failure to
    act”). Indeed, this Court has repeatedly noted the applicable
    test is not whether there are further administrative
    9
    proceedings available, but rather “whether the impact of the
    order is sufficiently ‘final’ to warrant review in the context of
    the particular case.” Envtl. Def. Fund, Inc. v. Ruckelshaus,
    
    439 F.2d 584
    , 591 (D.C. Cir. 1971) (assessing the Federal
    Insecticide, Fungicide, and Rodenticide Act’s provision for
    judicial review “[i]n a case of actual controversy as to the
    validity of any order” of the Secretary of Agriculture as
    articulated in 7 U.S.C. § 135b(d) (1970)); Ciba-Geigy Corp.
    v. EPA, 
    801 F.2d 430
    , 435–37 (D.C. Cir. 1986) (finding final
    agency action where a letter from the Environmental
    Protection Agency confirmed its policy with respect to new
    labeling changes and noting “[o]nce the agency publicly
    articulates an unequivocal position . . . and expects regulated
    entities to alter their primary conduct to conform to that
    position, the agency has voluntarily relinquished the benefit
    of postponed judicial review”); Envtl. Def. Fund, Inc. v.
    Hardin, 
    428 F.2d 1093
    , 1098–99 (D.C. Cir. 1970).
    Where an agency has clearly communicated it will not
    reach a determination on a petitioner’s submission due to
    petitioner’s recalcitrance but simultaneously refuses to deny
    the petitioner’s submission on those grounds, it has engaged
    in final agency action subject to this Court’s review. In
    Securitypoint Holdings, Inc. v. Transportation Security
    Administration, 
    769 F.3d 1184
    (D.C. Cir. 2014), for example,
    we reviewed as final agency action a letter from the
    Transportation Security Agency (“TSA”) Chief Counsel
    refusing to lift a contracting requirement newly imposed on
    TSA airport security checkpoint contractors. SecurityPoint
    sought to obtain the government contract, but it objected to
    and refused to sign TSA’s new Memorandum of
    Understanding (“MOU”) promising to indemnify TSA for
    intellectual property claims. 
    Id. at 1186.
    The company wrote
    to the TSA’s Chief Counsel to urge the agency to abandon the
    MOU, and TSA denied the request by letter. The Court later
    10
    held that letter represented the consummation of the agency’s
    “decisionmaking process regarding SecurityPoint’s contention
    that it should abandon the challenged alterations of the MOU
    language.” 
    Id. at 1187.
    Here, Friedman refuses to comply
    with the agency requirement he seeks to challenge, and the
    Agency has made clear it will not act on his application until
    he submits. Friedman, for his part, repeatedly asserts that he
    provided all that is required under the April 2015 AME
    Guide, and no FAA “regulation or policy require[s] the use of
    [CGM] for either initial certification or inflight monitoring.”
    JA 41–43. Accordingly, as with the TSA Chief Counsel’s
    letter in SecurityPoint, the FAA’s communications here
    represent the agency’s rejection of Friedman’s argument, its
    final decision to require CGM data, and its confirmation that
    it is not now opening the third-class applicants’ case-by-case
    exemption process to first-class applicants.
    The government, apparently ignoring the power of the
    Court to ensure justice in an area of law governed by a
    “pragmatic and flexible” approach, Rhea 
    Lana, 824 F.3d at 1027
    , is content to distinguish the cases cited by Friedman on
    their specific facts. Air One Helicopters, Inc. v. FAA, 
    86 F.3d 880
    (9th Cir. 1996), the Agency contends, applies only to a
    scenario where an agency and a private party find themselves
    at an impasse that neither is empowered to clear. Similarly,
    the FAA reads Air Line Pilots Ass’n International v. Civil
    Aeronautics Board, 
    750 F.2d 81
    (D.C. Cir. 1984), to apply
    only to situations where the private party has done everything
    in his power to comply with an agency’s request but the
    agency, nonetheless, excessively delays determination of his
    claims.      Finally, the FAA asserts the doctrine of
    Environmental Defense Fund, Inc. v. Hardin, 
    428 F.2d 1093
    ,
    1099 (D.C. Cir. 1970), reviewing “administrative inaction
    [that] has precisely the same impact on the rights of the
    parties as denial of relief,” does not apply since Friedman is
    11
    free to trigger a new six-month license validity period at his
    option. The Agency has missed the forest for the trees.
    Nothing in our case law suggests the law of final agency
    action is confined to the specific facts of prior circuit cases.
    To the contrary, the doctrine asks whether a particular
    agency action represents the “consummation of [its]
    decisionmaking process” and determines “rights or
    obligations.” 
    Bennett, 520 U.S. at 177
    –78. The standard is
    met here. As described above, the FAA has set deadlines,
    counted down towards them, and then allowed them to pass
    without discussion; its actions suggest the FAA has made up
    its mind, yet it seeks to avoid judicial review by holding out a
    vague prospect of reconsideration. And, as a result of the
    FAA’s conduct, Friedman has been unable to resume his job
    as a commercial airline pilot at American Airlines, a job that
    requires a first class medical certificate. See Safe Extensions,
    Inc. v. FAA, 
    509 F.3d 593
    , 598 (D.C. Cir. 2007) (finding
    adequate legal consequences where an agency’s new test for
    runway lighting “effectively prohibits airports from buying
    light bases that fail the new . . . test, and . . . bars
    manufacturers like Safe Extensions from selling their
    products to airports”).
    III.
    Since we hold Friedman’s case is subject to judicial
    review, we now proceed to the merits.
    The FAA argues Friedman’s claims are insulated from
    judicial scrutiny as “there is no law to apply” to the FAA’s
    determination. Drake v. FAA, 
    291 F.3d 59
    , 70 (D.C. Cir.
    2002); see also Citizens to Preserve Overton Park, Inc. v.
    Volpe, 
    401 U.S. 402
    , 410 (1971). But the jurisprudence of
    unfettered discretion is inapplicable here. Several regulations
    provide the criteria upon which the FAS relies to determine
    12
    whether Friedman may be granted a first-class certificate.
    Specifically, under 14 C.F.R. § 67.401(a), a special issuance
    may be granted “if the person shows to the satisfaction of the
    Federal Air Surgeon that the duties authorized by the class of
    medical certificate applied for can be performed without
    endangering public safety during the period in which the
    Authorization would be in force.” Later in that same section,
    the regulation charges the FAS with a duty to “consider[] the
    need to protect the safety of persons and property in other
    aircraft and on the ground.” 
    Id. § 67.401(e).
    While these
    directives are clearly open to interpretation, they nonetheless
    provide a judicially manageable standard. See, e.g., Safe
    
    Extensions, 509 F.3d at 601
    (finding a judicially manageable
    standard in the phrase “necessary for safety” under 49 U.S.C.
    § 44701); Union of Concerned Scientists v. U.S. Nuclear
    Regulatory Comm’n, 
    824 F.2d 108
    , 109, 113 (D.C. Cir. 1987)
    (reviewing whether regulations “provide[d] adequate
    protection to the health and safety of the public” under 42
    U.S.C. § 2232(a)).
    Arguing in the alternative, the FAA maintains
    Friedman’s license application was denied for refusal to
    comply with the Agency’s request for CGM data. To justify
    this decision, the FAA points to the Expert Panel’s letter in
    support of Friedman’s application, which acknowledged
    “CGM systems have value” and are “most useful in
    identifying trends and the direction and speed at which a
    person’s blood sugar may be changing.” JA 65–66. While
    the Expert Panel concluded treatment decisions for
    individuals with ITDM should not be based on CGM data
    alone—as the devices may be inaccurate and are, in any
    event, less accurate than fingerstick blood test results—it also
    noted CGM provides constant glucose monitoring results
    capable of detecting spikes and dips in interstitial glucose
    (indicative of actual blood glucose) that might have gone
    13
    undetected via intermittent fingerstick measurements. Ibid;
    see also ADA Amicus Br. 13–14. Nonetheless, the FAA
    overstates the usefulness of this concession, as the Expert
    Panel does not ultimately recommend employing CGM data
    “for making decisions on medical certification of pilots with
    diabetes.” JA 66. It is not for us to say in the first instance
    whether or how CGM data might be of future use to the FAA
    in evaluating license applications. But it is clear the FAA has
    not borne its burden of justification. The FAA’s letters
    communicating its demand for CGM data to Friedman,
    despite his many requests for clarification, fail to articulate
    any rationale for consideration of the additional information.
    See Safe 
    Extensions, 509 F.3d at 606
    (finding no “substantial
    evidence” to support the FAA’s rationale where it offered “no
    evidence whatsoever” on the relevant issue).
    Notably, the Agency does not identify any FAA
    statements that could be construed as explaining its denial of
    Friedman’s application, the determination Friedman calls
    upon this Court to review. Of course, there is a certain irony
    inherent in requiring an agency to identify reasons for a denial
    it never thought it issued. But “recent [D.C. Circuit] cases
    regarding whether agency actions qualify as orders never
    consider the adequacy of the record, instead asking only
    whether the action was final.” 
    Id. at 599
    (citing Dania 
    Beach, 485 F.3d at 1187
    ; Vill. of Bensenville v. FAA, 
    457 F.3d 52
    , 68
    (D.C. Cir. 2006)). As the Supreme Court explained,
    The focal point for judicial review should be
    the administrative record already in existence,
    not some new record made initially in the
    reviewing court. The task of the reviewing
    court is to apply the appropriate APA standard
    of review to the agency decision based on the
    record the agency presents to the reviewing
    14
    court. If the record before the agency does not
    support the agency action, if the agency has
    not considered all relevant factors, or if the
    reviewing court simply cannot evaluate the
    challenged agency action on the basis of the
    record before it, the proper course, except in
    rare circumstances, is to remand to the agency
    for additional investigation or explanation.
    Fla. Power & Light Co. v. Lorion, 
    470 U.S. 729
    , 743–44
    (1985). Specifically, “the court can undertake review as
    though the agency had denied the requested relief and can
    order an agency to either act or provide a reasoned
    explanation for its failure to act.” Sierra Club v. Thomas, 
    828 F.2d 783
    , 793 (D.C. Cir. 1987).
    In light of the complete absence of a relevant
    administrative record to review—and the inherent inequity in
    passing judgment on this matter without offering the Agency
    a chance to explain its reasoning—any analysis of the FAA’s
    denial would be imprudent. Accordingly, we remand this
    matter to the FAA to offer reasons for its denial of Friedman’s
    application for a first class medical certificate. Friedman’s
    additional allegations must await proceedings on remand.
    15
    ***
    The FAA has placed Friedman in administrative limbo—
    he has neither a first class medical certificate nor an official
    order denying him the certificate—and the only way out
    requires capitulation to the very requirement he seeks to
    challenge. The Agency cannot manipulate its own processes,
    threatening denial but then refusing to deny or otherwise take
    definitive action on Friedman’s application, in an effort to
    thwart judicial review.
    So ordered.